194 related articles for article (PubMed ID: 30114962)
21. Targeting kallikrein-related peptidases in prostate cancer.
Mavridis K; Avgeris M; Scorilas A
Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
[TBL] [Abstract][Full Text] [Related]
22. Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.
Stefanini AC; da Cunha BR; Henrique T; Tajara EH
Dis Markers; 2015; 2015():946572. PubMed ID: 26783378
[TBL] [Abstract][Full Text] [Related]
23. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
24. Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
Oikonomopoulou K; Batruch I; Smith CR; Soosaipillai A; Diamandis EP; Hollenberg MD
Biol Chem; 2010 Apr; 391(4):381-90. PubMed ID: 20180649
[TBL] [Abstract][Full Text] [Related]
25. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
26. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
[TBL] [Abstract][Full Text] [Related]
27. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
28. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
[TBL] [Abstract][Full Text] [Related]
29. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
[TBL] [Abstract][Full Text] [Related]
30. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
32. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
Shahinian H; Loessner D; Biniossek ML; Kizhakkedathu JN; Clements JA; Magdolen V; Schilling O
Mol Oncol; 2014 Feb; 8(1):68-82. PubMed ID: 24120346
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM
Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686
[TBL] [Abstract][Full Text] [Related]
34. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
[TBL] [Abstract][Full Text] [Related]
35. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
36. Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
Debela M; Beaufort N; Magdolen V; Schechter NM; Craik CS; Schmitt M; Bode W; Goettig P
Biol Chem; 2008 Jun; 389(6):623-32. PubMed ID: 18627343
[TBL] [Abstract][Full Text] [Related]
37. Functional roles of human kallikrein-related peptidases.
Sotiropoulou G; Pampalakis G; Diamandis EP
J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
39. Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.
de Veer SJ; Furio L; Swedberg JE; Munro CA; Brattsand M; Clements JA; Hovnanian A; Harris JM
J Invest Dermatol; 2017 Feb; 137(2):430-439. PubMed ID: 27697464
[TBL] [Abstract][Full Text] [Related]
40. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Emami N; Diamandis EP
Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]